Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Mol Cancer Res. 2009 Jul 7;7(7):1132–1138. doi: 10.1158/1541-7786.MCR-09-0068

Figure 4.

Figure 4

Class III PI3K, hVps34 is not oncogenic in CEF. (A) Focus formation of indicated constructs. RCAS(A) is shown as a negative control, p110α H1047R and p110δ serve as positive controls. (B) Vps34 and Myr-Vps34 do not activate PI3K targets under normal (left panel) or low serum conditions (right panel). Both proteins are VSV-G tagged and detected with a specific antibody against the VSV-G epitope.